TBUFF: Tribute Pharmaceuticals Canada Inc. (“Tribute”) will complete a plan of arrangement (the “Arrangement”) with Aralez Pharmaceuticals Inc. (“Aralez”) and ARLZ CA Acquisition Corp., resulting in Tribute becoming a wholly-owned subsidiary of Aralez. Pursuant to the Agreement, Pozen Inc. will merge with a wholly-owned subsidiary of Aralez and will become a wholly-owned subisidiary of Aralez. Shareholders of the Company shall receive 0.1455 shares of Aralez for each share of the Company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.